Bile duct cancer, Biliary tree cancers, Gallbladder cancer
Open
Phase 3
This trial is looking at adding a drug called rilvegostomig to chemotherapy for bile duct and gallbladder cancer.
It is for people who have had surgery to completely remove their cancer with the aim to cure.
You pronounce rilvegostomig as ril–veh–gost-oh-mig.
Recruitment start: 1 May 2024
Recruitment end: 30 September 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Roopinder Gillmore
AstraZeneca
Last reviewed: 5 June 2025
CRUK internal database number: 20026
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
